IKT
(NASDAQ)Inhibikase Therapeutics, Inc.
$1.69-- (--)
Loading... - Market loading
Inhibikase Therapeutics (IKT) Stock Price & Financial Analysis
Inhibikase Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Day's Range$1.65 - $1.72
52-Week High$3.32
52-Week Low$1.33
Open$1.67
Volume542.48K
Average Volume (3M)542.48K
Market Cap152.19M
Shares Outstanding90.05M
Price to Sales (P/S)808.55
Price to Book (P/B)2.09
EV/EBITDA-2.20
Revenue (TTM)188.22K
Net Income (TTM)-47.66M
Free Cash Flow (TTM)-25.85M
EPS (TTM)$-0.53
Profit Margin-25319.63%
Operating Margin-28234.46%
Return on Equity (ROE)-65.37%
Debt to Equity0.00
50-Day MA$1.68
200-Day MA$1.72
52-Week Change-28.09%
Annual Dividend$0.00
Dividend Yield0.00%
Day's Range$1.65 - $1.72
52-Week High$3.32
52-Week Low$1.33
Open$1.67
Volume542.48K
Average Volume (3M)542.48K
Market Cap152.19M
Shares Outstanding90.05M
Price to Sales (P/S)808.55
Price to Book (P/B)2.09
EV/EBITDA-2.20
Revenue (TTM)188.22K
Net Income (TTM)-47.66M
Free Cash Flow (TTM)-25.85M
EPS (TTM)$-0.53
Profit Margin-25319.63%
Operating Margin-28234.46%
Return on Equity (ROE)-65.37%
Debt to Equity0.00
50-Day MA$1.68
200-Day MA$1.72
52-Week Change-28.09%
Annual Dividend$0.00
Dividend Yield0.00%
Latest News
Recent news and articles about IKT